title: Cisplatin plus vinorelbine for patients with advanced head and neck squamous cell carcinoma.
authors.affiliation: Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Segura
authors.forename: M
authors.initials: M
authors.lastname: Pastor
authors.forename: A
authors.initials: A
authors.lastname: Santaballa
authors.forename: A
authors.initials: A
authors.lastname: Yuste
authors.forename: P
authors.initials: P
authors.lastname: López
authors.forename: J
authors.initials: J
authors.lastname: Aparicio
mesh_terms: D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D000077235:Vinorelbine
chemical_list: D014747:Vinblastine; D002945:Cisplatin; D000077235:Vinorelbine